Comparison of azapropazone and naproxen in rheumatoid arthritis
- 1 January 1976
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 4 (4) , 285-289
- https://doi.org/10.1185/03007997609109319
Abstract
A double-blind crossover trial was carried out in 15 patients with definite rheumatoid arthritis to compare the effectiveness of 1200 mg azapropazone daily and 750 mg naproxen daily, each drug being given for 2 weeks. Patients also received placebo therapy before and between the two treatment periods. The results of subjective and objective assessments showed that both drugs were significantly superior to placebo, but no significant difference could be demonstrated between the two drugs.Keywords
This publication has 13 references indexed in Scilit:
- Editorial: Antirheumatic drugs: plenty is not enough.BMJ, 1976
- Gastro-intestinal bleeding in patients with rheumatoid arthritis: the effects of azapropazone treatmentCurrent Medical Research and Opinion, 1976
- An assessment of the therapeutic potential of azapropazone in rheumatoid arthritisCurrent Medical Research and Opinion, 1976
- Toxicological studies on azapropazoneCurrent Medical Research and Opinion, 1976
- Clinical assessment of azapropazone in rheumatoid arthritisCurrent Medical Research and Opinion, 1976
- The pharmacology and pharmacokinetics of azapropazone - a reviewCurrent Medical Research and Opinion, 1976
- Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1974
- A Multi-Center Double-Blind Crossover Comparison Study of Naproxen and Aspirin in Patients with Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1973
- Pulmonary sensitivity to nitrofurantoin.BMJ, 1970
- 1958 Revision of diagnostic criteria for rheumatoid arthritisArthritis & Rheumatism, 1959